Therapeutic effect of apple pectin in obese rats.
Obesity is the most common nutritional disorder and is associated with significant comorbidities such as dyslipidemia, atherosclerosis and type 2 diabetes. This pathology is changing worldwide and is a risk factor for cardiovascular disease. This study, carried out on adult male Wistar rats, evaluates the inhibitory effects of supplementation with apple pectin molecule on obesity. Under our experimental conditions, administration of pectin molecule decreased 1) the total cholesterol (TC), LDL-cholesterol (LDL-ch) and triglycerides (TG) levels as well as ASAT, ALAT, LDH, ALP, UREA and uric acid (UC) levels in blood serum; and 2) increased the creatinine levels (CREA), compared to HFD group. TBARS concentrations decreased in liver, kidney, and serum by 20%, 29% and 19%, respectively, in a group treated with high-fat diet and pectin (HFD+Pec) compared to a HFD-treated group. The same treatment with pectin molecule increased superoxide dismutase, glutathion peroxidase and catalase activities by 39%, 14% and 16% in liver; 5%, 7% and 31% in kidney; and 9%, 32% and 22% in blood serum in the HFD Pec-treated group. The anti-obesity effects of the pectin molecule in several organs are mainly due to the interaction of this molecule with both the polysaccharide and the enzyme system which can be determined by phytochemical analysis.